Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Lancet (London, England)|May 25, 1985
Prognosis in Guillain-Barré syndromeJ B Winer, R A Hughes, R J Greenwood, et al.Neurology|October 1, 1986
Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytesK Selmaj, C Plater-Zyberk, K A Rockett, et al.Epilepsia|July 1, 1999
Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoinT J Steiner, C I Dellaportas, L J Findley, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1997
Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-alpha and soluble adhesion moleculesA J Vora, D Kidd, D H Miller, et al.Neurology|July 1, 1989
Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MSA J Thompson, C Kennard, M Swash, et al.Clinical Nephrology|May 1, 1984
Rhabdomyolysis and acute renal failure in chronic alcoholics with myopathy, unrelated to acute alcohol ingestionD Saltissi, P S Parfrey, J R Curtis, et al.Neurology|April 28, 2004
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodiesD J H McCabe, N C Turner, D Chao, et al.Lancet (London, England)|March 29, 1997
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosisD Barnes, R A Hughes, R W Morris, et al.Journal of the Neurological Sciences|February 17, 2000
The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosisB Sharrack, R A Hughes, R W Morris, et al.Brain : a Journal of Neurology|October 26, 2000
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activityR B Banati, J Newcombe, R N Gunn, et al.Pageof 4